drugset / Trial / NCT04854551

Opioid Modulation and Neural Reward Activation in Healthy Adults

NCT04854551

Phase 1/2 Completed 13 enrolled University of Colorado, Denver
RandomizedCrossoverTriple-blindBasic science

Summary

This is a double blind study of the effects of opioid antagonism on the brain's reward response. The investigators will recruit participants to undergo two scans, one on active medication and one on placebo. During the scan, the investigators will assess reward.

Timeline

Start
2021-05-01
Primary completion
2022-04-18
Completion
2022-04-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg